相关实验视频
Updated: Jun 16, 2025

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
25.0K
[工程外体在肺癌治疗中的研究进展]
1Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|August 15, 2024
概括
在传统疗法失败时,工程外体对治疗肺癌充满希望. 本综述探讨了它们在改善肺癌治疗结果方面的潜在应用.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 非小细胞肺癌 (NSCLC) 往往呈现于晚期,限制了手术选择.
- 目前的化疗和放射治疗等治疗方法面临诸如耐药性和有效性有限等挑战.
- 对于抗击肺癌的新型治疗策略有着至关重要的需要.
研究的目的:
- 审查工程外体在肺癌治疗中的当前应用.
- 总结关于肺癌工程外体治疗的研究成果.
- 突出工程外体的潜力作为肺癌的新治疗方法.
主要方法:
- 对肺癌治疗工程外体的研究进行文献综述.
- 分析针对药物向和治疗效果的外体工程研究.
- 综合关于工程外体基肺癌疗法的疗效和挑战的发现.
主要成果:
- 工程外体在临床前模型中显示出治疗肺癌的潜力.
- 外体可以被修改为专门向肺癌细胞输送治疗剂.
- 研究表明,工程外体可能克服药物耐药性并提高治疗效率.
结论:
- 工程外体构成肺癌治疗的前沿前沿.
- 需要进一步的研究和临床试验,以将工程外体潜力转化为有效的肺癌治疗方法.
- 这项技术为开发下一代肺癌疗法提供了一个新的平台.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

